arrow
F

Frank Behrens

Goethe University Frankfurt
H指数:36
被引数:7,440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective; open-label; randomized pilot study

鼠尾草-常春藤糖浆对轻度COVID-19患者抗病毒免疫反应的影响:一项前瞻性、开放标签、随机试点研究

2025-10-220
OAAI
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study

疾病相关脑激活预测类风湿关节炎中TNF抑制的临床反应(PreCePra):一项随机、多中心、双盲、安慰剂对照的III期研究

2025-06-230
OAAI
Guselkumab and IL-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis outcomes: 6-month interim results of the PsABIOnd observational cohort study

Guselkumab和IL-17抑制剂在银屑病关节炎结局方面显示出可比的治疗持续性和有效性:PsABIOnd观察性队列研究的6个月中期结果

2025-04-280
PRE
Guselkumab and IL-17 inhibitors improve patient-perceived impact of psoriatic arthritis similarly: 6-month interim results of the PsABIOnd observational cohort study

Guselkumab和IL-17抑制剂对银屑病关节炎患者感知影响的改善效果相似:PsABIOnd观察性队列研究的6个月中期结果

2025-04-280
PRE
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
LANCET
IF88.5
2024-03-0130
PRE
Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units
TALANTA
IF6.1
2024-02-014
OAAI
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis

应用临床和分子谱分析数据改善银屑病关节炎患者的预后

2023-09-084
OAAI
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries

皮肤病和风湿病护理中银屑病关节炎患者的特征: 两个注册表的分析

2023-08-313
OAAI